1 |
Alberti KGMM, Zimmet PZ. 1998. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetes Med 13: 539-553
|
2 |
Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L. 2002. Antidiabetic effects of Panax ginseng berry extract and the indentification of an effective components. Diabetes 51:1851- 1858
DOI
ScienceOn
|
3 |
D'Agostino RB, Hamman RF, Karter AJ, Mykkanen L, Wagenkencht LE, Haffiner SM. 2004. Cardiovascular disease risk factors predict the development of type 2 diabetes: The insulin resistance atherosclerosis study. Diabetes Care 27: 2234-2240
DOI
ScienceOn
|
4 |
DeFronzo RA. 1988. The triumvirate: Beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667-687
DOI
|
5 |
Hasegawa H, Sung JH, Huh JD. 1997a. Ginseng intestinal bacteria metabolite IH901 as a new antimetastatic agent. Arch Pharm Res 20:539-544
DOI
ScienceOn
|
6 |
Kang KS, Kim HY, Pyo JS, Yokozawa T. 2006. Increase in the free radical scavenging activity of ginseng by heat-processing. Biol Pharm Bull 29:750-754
DOI
ScienceOn
|
7 |
Kato A, Miura T. 1994. Hypoglycemic action of rhizomes of polygonatum officinale in normal and diabetic mice. Planta Med 60:201-203
DOI
ScienceOn
|
8 |
Keum YS, Han SS, Chun KS, Park KK, Park JH, Lee SK. 2003. Inhibitory effects of the ginsenoside Rg3 on phorbol esterinduced cyclooxygenase-2 expression, NF-kappaB activation and turmor promotion. Mutat Res 523-524:75-85
DOI
ScienceOn
|
9 |
Kim SN, Kang SJ. 2009. Effects of black ginseng (9 timessteaing ginseng) on hypoglycemic action and changes in the composition of ginsenosides on the steaming process. Korean J Food Sci Technol 41:77-81
|
10 |
Kim SW, Kwon HY, Chi DW, Shim JH, Park JD, Lee YH. 2003. Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg3. Biochem Pharmacol 65:75-82
DOI
ScienceOn
|
11 |
Lee JH, Shen GN, Kim EK, Shin JH, Myung CS, Oh HJ, Kim DH, Roh SS, Cho W, Seo YB, Park YJ, Kang CW, Song GY. 2006. Preparation of black ginseng and its antitumor activity. Korean J Orient Physiol Pathol 20:951-956
|
12 |
Lenhard JM, Gottschalk WK. 2002. Preclinical development in type 2 diabetes. Advanced Drug Delivery Reviews 54:1199- 1212
DOI
ScienceOn
|
13 |
lvorra MD, Paya M, Villar A. 1989. A review of natural products and plants as potential antidiabetic drugs. J Ethnopgarmacol 27:243-75
DOI
ScienceOn
|
14 |
Neef H, Declereq P, laekeman G. 1995. Hypoglycaemic activity of selected European plants. Phutother Res 9:45-48
DOI
ScienceOn
|
15 |
Noel PH, Pugh JA, Larne AC, Marsh G. 1997. The use of traditional plant medicines for non-insulin dependent diabetes mellitus in South Texas. Phutother Res 11:512-7
DOI
ScienceOn
|
16 |
Pan XR, Walden CE, Warnick GR, Hu SX, Alberts JJ, Cheung M, Bierman EL. 1986. Comparison of plasma lipoproteins and apoproteins in Chinese and American non-insulin dependent diabetic subjects and controls. Diabetes Care 9: 395-400
DOI
ScienceOn
|
17 |
Park SP, Ko SK, Chung SH. 2003. Comparisons of antidiabetic effect between ginseng radix, alba, ginseng radix rubra and Panax quinquefoli radix in MLD STZ-induced diabetic rats. J Ginseng Res 27:56-61
DOI
ScienceOn
|
18 |
Peter P, Nuttall SL, Kendall MJ. 2003. Insulin resistance-the new goal! J of Clinical Pharmacy and Therapeutics 28:167-174
DOI
ScienceOn
|
19 |
Pi-Sunyer FX. 2002. The obesity epidemic: Pathophysiology and consequences of obesity. Obese Res 210:97S-104
|
20 |
Scheen AJ. 2000. From obesity to diabetes: Why, when and who? Acta Clinica Belgica 55:9-15
DOI
|
21 |
Seidell JC. 2000. Obesity, insulin resistance and diabetes-a worldwide epidemic. British J of Nutr 83:S5-S8
|
22 |
Soonthornpun S, Rattarasarn C, Leelawattana R, Setasuban W. 1999. Postprandial plasma glucose: A good index of glycemic control in type 2 diabetic patients having near-normal fasting glucose levels. Diabetes Research and Clinical Practice 46:429-449
|
23 |
Turner RC. 1998. The UK prospective diabetes study. A review. Diabetes Care 21:C35-C38
DOI
|
24 |
Xie JT, Zhou Y-P, Zhang L, Dey L, Attele AS, Wu JA, Gu M. 2002b. Ginseng berry reduces blood glucose and body weight in db/db mice. Phytomedicine 9:254-258
DOI
ScienceOn
|
25 |
Vuksan V, Stavro MP, Sievenpiper JL, Beljan-Zdravkovic U, Leiter LA, Josse RG, Xu Z. 2000. Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes. Diabetes Care 23:1221-1226
DOI
ScienceOn
|
26 |
Wild S, Roglic G, Green A, Sicree R, King H. 2004. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053.
DOI
ScienceOn
|
27 |
Xie JT, Aung HH, Wu JA, Attele AS, Yuan C-S. 2002a. Effects of American ginseng berry extract on blood glucose levels in b/ob mice. Am J Chin Med 30:187-194
DOI
ScienceOn
|
28 |
Yun TK. 2003. Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds. Mutat Res 523:63-74.16
|
29 |
Zhang Ruxue, Zhou Jinhuang, Jia Zhengping, Zhang Youngxing, Gu Guoming. 2004. Hypoglycemic effect of Rehmannia glutinosa oligosaccharide in hyperglycemic and alloxan-induced diabetic rats and its mechanism. J of Ethnophamacology 90:39-43
DOI
ScienceOn
|